291. Hirschsprung disease, entire colon type Clinical trials / Disease details
Clinical trials : 14 / Drugs : 35 - (DrugBank : 15) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02216994 (ClinicalTrials.gov) | January 2013 | 6/8/2014 | A New Scoring System Improves Diagnostic Accuracy of Intestinal Dysganglionosis --a Prospective Study | Efficacy and Accuracy of a New Diagnostic Scoring System to Differentiate Hirschsprung Disease From Hirschsprung Disease Allied Disorders in the Patients With Suspected Intestinal Dysganglinosis: a Prospective Study | Hirschsprung Disease | Drug: high dose lactulose;Behavioral: conservative treatment;Drug: paraffin oil | Tongji Hospital | Jiangxi Provincial Children's Hospital | Recruiting | N/A | 3 Years | Both | 80 | N/A | China |